Cocrystal Pharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
589.50
5,945.00
9,276.00
3,640.00
777.00
2,752
Total Accounts Receivable
-
287.00
202.00
1,315.00
1,295.00
-
Other Current Assets
5,866.80
144.00
441.00
517.00
104.00
191
Total Current Assets
6,456.30
6,376.00
9,919.00
5,472.00
2,176.00
2,943
Net Property, Plant & Equipment
-
284.00
430.00
280.00
119.00
384
Total Investments and Advances
-
-
-
-
31.00
-
Long-Term Note Receivable
-
2,431.00
2,354.00
-
-
-
Intangible Assets
-
250,161.00
211,496.00
119,100.00
119,100.00
65,195
Other Assets
-
31.00
31.00
31.00
-
40
Total Assets
6,456.30
267,473.00
240,701.00
148,795.00
139,560.00
88,341
Accounts Payable
-
299.00
-
563.00
837.00
Other Current Liabilities
12,482.50
8,858.00
6,700.00
1,476.00
569.00
Total Current Liabilities
12,482.50
9,157.00
6,700.00
2,039.00
1,406.00
Long-Term Debt
-
-
-
-
1,007.00
Deferred Taxes
-
65,195.00
49,875.00
20,462.00
13,582.00
Other Liabilities
-
62.00
61.00
63.00
31.00
Total Liabilities
12,482.50
82,604.00
73,107.00
46,476.00
34,160.00
Common Equity (Total)
6,026.20
6,650.00
167,594.00
102,319.00
105,400.00
Total Shareholders' Equity
6,026.20
184,869.00
167,594.00
102,319.00
105,400.00
Total Equity
6,026.20
184,869.00
167,594.00
102,319.00
105,400.00
Liabilities & Shareholders' Equity
6,456.30
267,473.00
240,701.00
148,795.00
139,560.00
Preferred Stock (Carrying Value)
-
178,219.00
-
-
-
About Cocrystal Pharma
View Profile
